Rey EBN, Pardo GME, Fuentes GH

Language: Spanish
References: 11
Page: 628-634
PDF size: 496.01 Kb.

ABSTRACT

The presence of the retinal edema is defined as an increase of liquid at histological level that causes swelling of the retina. Also, some fundamental aspects of the diabetic macular edema are exposed, such as pathophysiology, classification, epidemiologic risk factors, diagnosis and treatment.

REFERENCES

1. Romero P, Almena M, Baget M, Méndez I, Salvat M. Actualización en la epidemiología del edema macular diabético. Annals d’Oftalmología. 2005; 13(2):92-102.

2. Cunha Vaz J. Diabetic macular edema. Eur J Ophthalmol. 1998; 8(3):127-30.

3. Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema: pathophisiology, screening, and novel therapies. Diabetes Care. 2003; 26(9):2653-64.

4. Singh A, Stewart JM. Edema macular. Patofisiología del edema macular diabético. [citado 12 Dic 2016].

5. López Gálveza MI, García Campos JM. De la evidencia científica a la práctica clínica: pautas de tratamiento del edema macular diabético. Arch Soc Esp Oftalmol. 2012; 87(Supl 1):39.

6. Danis RP, Scott IU, Qin H, Altaweel MM, Bressler NM, Bressler SB, et al. Association of fluorescein angiographic features with visual acuity and with optical coherence tomographic and stereoscopic color fundus photographic features of diabetic macular edema in a randomized clinical trial. Retina. 2010; 30(10):1627-37.

7. Guerra García RA. Introducción a la microperimetría en las enfermedades maculares más frecuentes. En: Río Torres M, Capote Cabrera A, Padilla González CM, Eguía Martínez F, Hernández Silva JR. Oftalmología. Criterios y tendencias actuales. La Habana: Editorial Ciencias Médicas; 2009. p. 430-2.

8. Jonson MW. Edema Macular. Parte II. Am J Ophthalmol. 2009;147:11–21.

9. Study research group. Photocoagulation for diabetic macular edema. Arch Ophthalmol. 1985;103(12):1796-806.

10. Nguyen QD, Tatlipinar S, Shah SM, Haller JA, Quinlan E, Sung J, et al. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am J Ophthalmol. 2006; 142(6): 961-9.

11. Paccola L, Costa RA, Folgosa MS, Barbosa JC, Scott IU, Jorge R. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study). Br J Ophthalmol. 2008; 92(1):76-80.